z-logo
open-access-imgOpen Access
Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis
Author(s) -
Liuting Zhou,
Zhenyan Ye,
Erqing Zhang,
Li Chen,
Yitong Hou,
Jianping Lin,
Fenglan Huang,
Zhixiang Yuan
Publication year - 2022
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s347164
Subject(s) - nanocarriers , plga , drug delivery , fibrosis , pharmacology , materials science , medicine , pathology , nanoparticle , nanotechnology
Mesangial cells-mediated glomerulonephritis refers to a category of immunologically mediated glomerular injuries characterized by infiltration of circulating inflammatory cells, proliferation of mesangial cells, and the common pathological manifestation to the later stage is renal fibrosis, accompanied by excessive accumulation of extracellular matrix (ECM). Treatment regimens include glucocorticoids and immunosuppressive agents, but their off-target distribution causes severe systemic toxicity. Hence, specific co-delivery of "anti-inflammatory/anti-fibrosis" drugs to the glomerular mesangial cell (MC) region is expected to produce better therapeutic effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here